These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12056536)

  • 1. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters.
    Singh B; Ahuja N
    Drug Dev Ind Pharm; 2002 Apr; 28(4):431-42. PubMed ID: 12056536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel bioadhesive buccal formulation of diltiazem: in vitro and in vivo characterization.
    Shayeda ; Gannu R; Palem CR; Rao YM
    PDA J Pharm Sci Technol; 2009; 63(5):401-8. PubMed ID: 20158046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and in vitro evaluation of buccoadhesive carvedilol tablets.
    Yamsani VV; Gannu R; Kolli C; Rao ME; Yamsani MR
    Acta Pharm; 2007 Jun; 57(2):185-97. PubMed ID: 17507315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.
    Limpongsa E; Umprayn K
    AAPS PharmSciTech; 2008; 9(2):464-70. PubMed ID: 18431661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps.
    Prabakaran D; Singh P; Kanaujia P; Vyas SP
    Int J Pharm; 2003 Jun; 259(1-2):173-9. PubMed ID: 12787645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and in vitro/in vivo evaluation of the buccal bioadhesive properties of slow-release tablets containing miconazole nitrate.
    Mohammed FA; Khedr H
    Drug Dev Ind Pharm; 2003 Mar; 29(3):321-37. PubMed ID: 12741613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel buccal adhesive tablets using Aloe vera L and Sinapis alba--a promising option for improved bioavailability of diltiazem hydrochloride.
    Sudhakar Y; Bandyopadhyay AK
    PDA J Pharm Sci Technol; 2008; 62(2):97-110. PubMed ID: 18540536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
    Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
    Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. Diltiazem hydrochloride.
    Kim H; Fassihi R
    Pharm Res; 1997 Oct; 14(10):1415-21. PubMed ID: 9358555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate statistical approach to optimizing sustained-release tablet formulations containing diltiazem hydrochloride as a model highly water-soluble drug.
    Kikuchi S; Takayama K
    Int J Pharm; 2010 Feb; 386(1-2):149-55. PubMed ID: 19922778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization.
    Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
    Int J Pharm; 2007 Mar; 333(1-2):136-42. PubMed ID: 17207943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
    Gohel MC; Amin AF; Patel KV; Panchal MK
    Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and study of lamivudine oral controlled release tablets.
    Ravi PR; Ganga S; Saha RN
    AAPS PharmSciTech; 2007 Dec; 8(4):E101. PubMed ID: 18181522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril floating and/or bioadhesive tablets: design and release kinetics.
    Nur AO; Zhang JS
    Drug Dev Ind Pharm; 2000 Sep; 26(9):965-9. PubMed ID: 10914320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoadhesive delivery systems. II. Formulation and in-vitro/in-vivo evaluation of buccal mucoadhesive tablets containing water-soluble drugs.
    Nafee NA; Ismail FA; Boraie NA; Mortada LM
    Drug Dev Ind Pharm; 2004; 30(9):995-1004. PubMed ID: 15554224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buccal bioadhesive delivery system of 5-fluorouracil: optimization and characterization.
    Dhiman MK; Yedurkar PD; Sawant KK
    Drug Dev Ind Pharm; 2008 Jul; 34(7):761-70. PubMed ID: 18612914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
    Asare-Addo K; Conway BR; Larhrib H; Levina M; Rajabi-Siahboomi AR; Tetteh J; Boateng J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Nov; 111():384-91. PubMed ID: 23850747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of sustained-release propranolol dosage form using factorial design and response surface methodology.
    Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC
    Biol Pharm Bull; 2004 Oct; 27(10):1626-9. PubMed ID: 15467208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
    Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
    Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.